Microbiota of the first‐pass meconium and subsequent atopic and allergic disorders in children
Background Some cohort studies have suggested that gut microbiota composition is associated with allergic diseases in children. The microbiota of the first‐pass meconium, which forms before birth, represents the first gut microbiota that is easily available for research and little is known about any...
Gespeichert in:
Veröffentlicht in: | Clinical and experimental allergy 2022-05, Vol.52 (5), p.684-696 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 696 |
---|---|
container_issue | 5 |
container_start_page | 684 |
container_title | Clinical and experimental allergy |
container_volume | 52 |
creator | Kielenniva, Katja Ainonen, Sofia Vänni, Petri Paalanne, Niko Renko, Marjo Salo, Jarmo Tejesvi, Mysore V. Pokka, Tytti Pirttilä, Anna Maria Tapiainen, Terhi |
description | Background
Some cohort studies have suggested that gut microbiota composition is associated with allergic diseases in children. The microbiota of the first‐pass meconium, which forms before birth, represents the first gut microbiota that is easily available for research and little is known about any relationship with allergic disease development.
Objective
We investigated whether the bacterial composition of the first‐pass meconium is associated with the development of allergic diseases before 4 years of age.
Methods
Prospective birth cohort study. Bacterial composition of first‐pass meconium was analysed using bacterial 16S rRNA gene amplicon sequencing. Atopic and allergic diseases were evaluated via online survey or telephone to age 4 years, based on the International Study of Asthma and Allergies in Childhood questionnaire.
Results
During a 6‐week period in 2014, 312 children were born at the Central Finland Central Hospital. Meconium was collected from 212 at a mean of 8‐hour age. Outcome data at 4 years were available for 177 (83%) children, and 159 of these had sufficient amplification of bacterial DNA in meconium. Meconium microbiota composition, including diversity indices and relative abundances of the main phyla and genera, was not associated with subsequent atopic eczema, wheezing or cow's milk allergy. Principal components analysis did not identify any clustering of the meconium microbiomes of children with respect to wheezing or cow's milk allergy.
Conclusions
We found no evidence that gut microbiota composition of first‐pass meconium is associated with atopic manifestations to age 4 years. However, larger studies are needed to fully exclude a relationship.
Gut microbiota composition of the first stool after birth and the development of allergic diseases before 4 years of age were investigated in a population‐based cohort study of 212 infants. Atopic and allergic diseases were evaluated at 4 years of age and outcome data were available for 177 (83%) of the children. Meconium microbiota composition, including bacterial diversity indices and relative abundances of the main phyla and genera, was not associated with subsequent atopic eczema, wheezing or cow's milk allergy. |
doi_str_mv | 10.1111/cea.14117 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9314137</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2655443582</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4437-44782023051f5f7a9419c78888c0d7609a9b62370127f13cc83ced7b831572e93</originalsourceid><addsrcrecordid>eNp1kctKxDAYhYMoznhZ-AIScKOLOrk0k2QjyOANFDe6jmmazmRomzFpFXc-gs_okxgdFRX8NyHJx-Gc_wCwg9EhTjMyVh_iHGO-AoaYjllG0qyCIZIsz7iQ-QBsxDhHCFEmxToYUEYwQUwMwd2VM8EXznca-gp2MwsrF2L3-vyy0DHCxhrfur6Bui1h7Ito73vbdlB3fuHMx6uuaxum6VK66ENpQ4SuhWbm6jLYdgusVbqOdvvz3AS3pyc3k_Ps8vrsYnJ8mZk8pzzLcy4IIhQxXLGKa5ljabhIY1DJx0hqWYwJ5QgTXmFqjKDGlrwQFDNOrKSb4Gipu-iLxpYmmQy6VovgGh2elNdO_f5p3UxN_YOSNK2O8iSw_ykQfMoYO9W4aGxd69b6PioyplQwJPA7uvcHnfs-tCleohhLgZggiTpYUmnBMQZbfZvBSL33plJv6qO3xO7-dP9NfhWVgNESeHS1ffpfSU1OjpeSbxwuolE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2655443582</pqid></control><display><type>article</type><title>Microbiota of the first‐pass meconium and subsequent atopic and allergic disorders in children</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Kielenniva, Katja ; Ainonen, Sofia ; Vänni, Petri ; Paalanne, Niko ; Renko, Marjo ; Salo, Jarmo ; Tejesvi, Mysore V. ; Pokka, Tytti ; Pirttilä, Anna Maria ; Tapiainen, Terhi</creator><creatorcontrib>Kielenniva, Katja ; Ainonen, Sofia ; Vänni, Petri ; Paalanne, Niko ; Renko, Marjo ; Salo, Jarmo ; Tejesvi, Mysore V. ; Pokka, Tytti ; Pirttilä, Anna Maria ; Tapiainen, Terhi</creatorcontrib><description>Background
Some cohort studies have suggested that gut microbiota composition is associated with allergic diseases in children. The microbiota of the first‐pass meconium, which forms before birth, represents the first gut microbiota that is easily available for research and little is known about any relationship with allergic disease development.
Objective
We investigated whether the bacterial composition of the first‐pass meconium is associated with the development of allergic diseases before 4 years of age.
Methods
Prospective birth cohort study. Bacterial composition of first‐pass meconium was analysed using bacterial 16S rRNA gene amplicon sequencing. Atopic and allergic diseases were evaluated via online survey or telephone to age 4 years, based on the International Study of Asthma and Allergies in Childhood questionnaire.
Results
During a 6‐week period in 2014, 312 children were born at the Central Finland Central Hospital. Meconium was collected from 212 at a mean of 8‐hour age. Outcome data at 4 years were available for 177 (83%) children, and 159 of these had sufficient amplification of bacterial DNA in meconium. Meconium microbiota composition, including diversity indices and relative abundances of the main phyla and genera, was not associated with subsequent atopic eczema, wheezing or cow's milk allergy. Principal components analysis did not identify any clustering of the meconium microbiomes of children with respect to wheezing or cow's milk allergy.
Conclusions
We found no evidence that gut microbiota composition of first‐pass meconium is associated with atopic manifestations to age 4 years. However, larger studies are needed to fully exclude a relationship.
Gut microbiota composition of the first stool after birth and the development of allergic diseases before 4 years of age were investigated in a population‐based cohort study of 212 infants. Atopic and allergic diseases were evaluated at 4 years of age and outcome data were available for 177 (83%) of the children. Meconium microbiota composition, including bacterial diversity indices and relative abundances of the main phyla and genera, was not associated with subsequent atopic eczema, wheezing or cow's milk allergy.</description><identifier>ISSN: 0954-7894</identifier><identifier>EISSN: 1365-2222</identifier><identifier>DOI: 10.1111/cea.14117</identifier><identifier>PMID: 35212058</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>16S rRNA ; Age ; Allergic diseases ; allergic disorders ; Animals ; Asthma ; atopic eczema ; Atopy ; Bacteria ; Cattle ; Children ; Cohort Studies ; Cow's milk ; cow's milk allergy ; Dermatitis, Atopic ; Diversity indices ; Eczema ; Feces ; Female ; Food allergies ; Humans ; Hypersensitivity ; Infant, Newborn ; Intestinal microflora ; Meconium ; Microbiomes ; Microbiota ; Milk ; Milk Hypersensitivity - complications ; Original ; Principal components analysis ; Prospective Studies ; Respiratory Sounds ; RNA, Ribosomal, 16S - genetics ; rRNA 16S ; Wheezing</subject><ispartof>Clinical and experimental allergy, 2022-05, Vol.52 (5), p.684-696</ispartof><rights>2022 The Authors. published by John Wiley & Sons Ltd.</rights><rights>2022 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd.</rights><rights>2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4437-44782023051f5f7a9419c78888c0d7609a9b62370127f13cc83ced7b831572e93</citedby><cites>FETCH-LOGICAL-c4437-44782023051f5f7a9419c78888c0d7609a9b62370127f13cc83ced7b831572e93</cites><orcidid>0000-0002-9182-8393 ; 0000-0001-7563-6466</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fcea.14117$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fcea.14117$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,777,781,882,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35212058$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kielenniva, Katja</creatorcontrib><creatorcontrib>Ainonen, Sofia</creatorcontrib><creatorcontrib>Vänni, Petri</creatorcontrib><creatorcontrib>Paalanne, Niko</creatorcontrib><creatorcontrib>Renko, Marjo</creatorcontrib><creatorcontrib>Salo, Jarmo</creatorcontrib><creatorcontrib>Tejesvi, Mysore V.</creatorcontrib><creatorcontrib>Pokka, Tytti</creatorcontrib><creatorcontrib>Pirttilä, Anna Maria</creatorcontrib><creatorcontrib>Tapiainen, Terhi</creatorcontrib><title>Microbiota of the first‐pass meconium and subsequent atopic and allergic disorders in children</title><title>Clinical and experimental allergy</title><addtitle>Clin Exp Allergy</addtitle><description>Background
Some cohort studies have suggested that gut microbiota composition is associated with allergic diseases in children. The microbiota of the first‐pass meconium, which forms before birth, represents the first gut microbiota that is easily available for research and little is known about any relationship with allergic disease development.
Objective
We investigated whether the bacterial composition of the first‐pass meconium is associated with the development of allergic diseases before 4 years of age.
Methods
Prospective birth cohort study. Bacterial composition of first‐pass meconium was analysed using bacterial 16S rRNA gene amplicon sequencing. Atopic and allergic diseases were evaluated via online survey or telephone to age 4 years, based on the International Study of Asthma and Allergies in Childhood questionnaire.
Results
During a 6‐week period in 2014, 312 children were born at the Central Finland Central Hospital. Meconium was collected from 212 at a mean of 8‐hour age. Outcome data at 4 years were available for 177 (83%) children, and 159 of these had sufficient amplification of bacterial DNA in meconium. Meconium microbiota composition, including diversity indices and relative abundances of the main phyla and genera, was not associated with subsequent atopic eczema, wheezing or cow's milk allergy. Principal components analysis did not identify any clustering of the meconium microbiomes of children with respect to wheezing or cow's milk allergy.
Conclusions
We found no evidence that gut microbiota composition of first‐pass meconium is associated with atopic manifestations to age 4 years. However, larger studies are needed to fully exclude a relationship.
Gut microbiota composition of the first stool after birth and the development of allergic diseases before 4 years of age were investigated in a population‐based cohort study of 212 infants. Atopic and allergic diseases were evaluated at 4 years of age and outcome data were available for 177 (83%) of the children. Meconium microbiota composition, including bacterial diversity indices and relative abundances of the main phyla and genera, was not associated with subsequent atopic eczema, wheezing or cow's milk allergy.</description><subject>16S rRNA</subject><subject>Age</subject><subject>Allergic diseases</subject><subject>allergic disorders</subject><subject>Animals</subject><subject>Asthma</subject><subject>atopic eczema</subject><subject>Atopy</subject><subject>Bacteria</subject><subject>Cattle</subject><subject>Children</subject><subject>Cohort Studies</subject><subject>Cow's milk</subject><subject>cow's milk allergy</subject><subject>Dermatitis, Atopic</subject><subject>Diversity indices</subject><subject>Eczema</subject><subject>Feces</subject><subject>Female</subject><subject>Food allergies</subject><subject>Humans</subject><subject>Hypersensitivity</subject><subject>Infant, Newborn</subject><subject>Intestinal microflora</subject><subject>Meconium</subject><subject>Microbiomes</subject><subject>Microbiota</subject><subject>Milk</subject><subject>Milk Hypersensitivity - complications</subject><subject>Original</subject><subject>Principal components analysis</subject><subject>Prospective Studies</subject><subject>Respiratory Sounds</subject><subject>RNA, Ribosomal, 16S - genetics</subject><subject>rRNA 16S</subject><subject>Wheezing</subject><issn>0954-7894</issn><issn>1365-2222</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp1kctKxDAYhYMoznhZ-AIScKOLOrk0k2QjyOANFDe6jmmazmRomzFpFXc-gs_okxgdFRX8NyHJx-Gc_wCwg9EhTjMyVh_iHGO-AoaYjllG0qyCIZIsz7iQ-QBsxDhHCFEmxToYUEYwQUwMwd2VM8EXznca-gp2MwsrF2L3-vyy0DHCxhrfur6Bui1h7Ito73vbdlB3fuHMx6uuaxum6VK66ENpQ4SuhWbm6jLYdgusVbqOdvvz3AS3pyc3k_Ps8vrsYnJ8mZk8pzzLcy4IIhQxXLGKa5ljabhIY1DJx0hqWYwJ5QgTXmFqjKDGlrwQFDNOrKSb4Gipu-iLxpYmmQy6VovgGh2elNdO_f5p3UxN_YOSNK2O8iSw_ykQfMoYO9W4aGxd69b6PioyplQwJPA7uvcHnfs-tCleohhLgZggiTpYUmnBMQZbfZvBSL33plJv6qO3xO7-dP9NfhWVgNESeHS1ffpfSU1OjpeSbxwuolE</recordid><startdate>202205</startdate><enddate>202205</enddate><creator>Kielenniva, Katja</creator><creator>Ainonen, Sofia</creator><creator>Vänni, Petri</creator><creator>Paalanne, Niko</creator><creator>Renko, Marjo</creator><creator>Salo, Jarmo</creator><creator>Tejesvi, Mysore V.</creator><creator>Pokka, Tytti</creator><creator>Pirttilä, Anna Maria</creator><creator>Tapiainen, Terhi</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9182-8393</orcidid><orcidid>https://orcid.org/0000-0001-7563-6466</orcidid></search><sort><creationdate>202205</creationdate><title>Microbiota of the first‐pass meconium and subsequent atopic and allergic disorders in children</title><author>Kielenniva, Katja ; Ainonen, Sofia ; Vänni, Petri ; Paalanne, Niko ; Renko, Marjo ; Salo, Jarmo ; Tejesvi, Mysore V. ; Pokka, Tytti ; Pirttilä, Anna Maria ; Tapiainen, Terhi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4437-44782023051f5f7a9419c78888c0d7609a9b62370127f13cc83ced7b831572e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>16S rRNA</topic><topic>Age</topic><topic>Allergic diseases</topic><topic>allergic disorders</topic><topic>Animals</topic><topic>Asthma</topic><topic>atopic eczema</topic><topic>Atopy</topic><topic>Bacteria</topic><topic>Cattle</topic><topic>Children</topic><topic>Cohort Studies</topic><topic>Cow's milk</topic><topic>cow's milk allergy</topic><topic>Dermatitis, Atopic</topic><topic>Diversity indices</topic><topic>Eczema</topic><topic>Feces</topic><topic>Female</topic><topic>Food allergies</topic><topic>Humans</topic><topic>Hypersensitivity</topic><topic>Infant, Newborn</topic><topic>Intestinal microflora</topic><topic>Meconium</topic><topic>Microbiomes</topic><topic>Microbiota</topic><topic>Milk</topic><topic>Milk Hypersensitivity - complications</topic><topic>Original</topic><topic>Principal components analysis</topic><topic>Prospective Studies</topic><topic>Respiratory Sounds</topic><topic>RNA, Ribosomal, 16S - genetics</topic><topic>rRNA 16S</topic><topic>Wheezing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kielenniva, Katja</creatorcontrib><creatorcontrib>Ainonen, Sofia</creatorcontrib><creatorcontrib>Vänni, Petri</creatorcontrib><creatorcontrib>Paalanne, Niko</creatorcontrib><creatorcontrib>Renko, Marjo</creatorcontrib><creatorcontrib>Salo, Jarmo</creatorcontrib><creatorcontrib>Tejesvi, Mysore V.</creatorcontrib><creatorcontrib>Pokka, Tytti</creatorcontrib><creatorcontrib>Pirttilä, Anna Maria</creatorcontrib><creatorcontrib>Tapiainen, Terhi</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical and experimental allergy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kielenniva, Katja</au><au>Ainonen, Sofia</au><au>Vänni, Petri</au><au>Paalanne, Niko</au><au>Renko, Marjo</au><au>Salo, Jarmo</au><au>Tejesvi, Mysore V.</au><au>Pokka, Tytti</au><au>Pirttilä, Anna Maria</au><au>Tapiainen, Terhi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Microbiota of the first‐pass meconium and subsequent atopic and allergic disorders in children</atitle><jtitle>Clinical and experimental allergy</jtitle><addtitle>Clin Exp Allergy</addtitle><date>2022-05</date><risdate>2022</risdate><volume>52</volume><issue>5</issue><spage>684</spage><epage>696</epage><pages>684-696</pages><issn>0954-7894</issn><eissn>1365-2222</eissn><abstract>Background
Some cohort studies have suggested that gut microbiota composition is associated with allergic diseases in children. The microbiota of the first‐pass meconium, which forms before birth, represents the first gut microbiota that is easily available for research and little is known about any relationship with allergic disease development.
Objective
We investigated whether the bacterial composition of the first‐pass meconium is associated with the development of allergic diseases before 4 years of age.
Methods
Prospective birth cohort study. Bacterial composition of first‐pass meconium was analysed using bacterial 16S rRNA gene amplicon sequencing. Atopic and allergic diseases were evaluated via online survey or telephone to age 4 years, based on the International Study of Asthma and Allergies in Childhood questionnaire.
Results
During a 6‐week period in 2014, 312 children were born at the Central Finland Central Hospital. Meconium was collected from 212 at a mean of 8‐hour age. Outcome data at 4 years were available for 177 (83%) children, and 159 of these had sufficient amplification of bacterial DNA in meconium. Meconium microbiota composition, including diversity indices and relative abundances of the main phyla and genera, was not associated with subsequent atopic eczema, wheezing or cow's milk allergy. Principal components analysis did not identify any clustering of the meconium microbiomes of children with respect to wheezing or cow's milk allergy.
Conclusions
We found no evidence that gut microbiota composition of first‐pass meconium is associated with atopic manifestations to age 4 years. However, larger studies are needed to fully exclude a relationship.
Gut microbiota composition of the first stool after birth and the development of allergic diseases before 4 years of age were investigated in a population‐based cohort study of 212 infants. Atopic and allergic diseases were evaluated at 4 years of age and outcome data were available for 177 (83%) of the children. Meconium microbiota composition, including bacterial diversity indices and relative abundances of the main phyla and genera, was not associated with subsequent atopic eczema, wheezing or cow's milk allergy.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>35212058</pmid><doi>10.1111/cea.14117</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-9182-8393</orcidid><orcidid>https://orcid.org/0000-0001-7563-6466</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0954-7894 |
ispartof | Clinical and experimental allergy, 2022-05, Vol.52 (5), p.684-696 |
issn | 0954-7894 1365-2222 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9314137 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | 16S rRNA Age Allergic diseases allergic disorders Animals Asthma atopic eczema Atopy Bacteria Cattle Children Cohort Studies Cow's milk cow's milk allergy Dermatitis, Atopic Diversity indices Eczema Feces Female Food allergies Humans Hypersensitivity Infant, Newborn Intestinal microflora Meconium Microbiomes Microbiota Milk Milk Hypersensitivity - complications Original Principal components analysis Prospective Studies Respiratory Sounds RNA, Ribosomal, 16S - genetics rRNA 16S Wheezing |
title | Microbiota of the first‐pass meconium and subsequent atopic and allergic disorders in children |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T09%3A24%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Microbiota%20of%20the%20first%E2%80%90pass%20meconium%20and%20subsequent%20atopic%20and%20allergic%20disorders%20in%20children&rft.jtitle=Clinical%20and%20experimental%20allergy&rft.au=Kielenniva,%20Katja&rft.date=2022-05&rft.volume=52&rft.issue=5&rft.spage=684&rft.epage=696&rft.pages=684-696&rft.issn=0954-7894&rft.eissn=1365-2222&rft_id=info:doi/10.1111/cea.14117&rft_dat=%3Cproquest_pubme%3E2655443582%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2655443582&rft_id=info:pmid/35212058&rfr_iscdi=true |